President Trump pumped the brakes last week on a pledge to shut down an import tax exemption for cheap consumer goods from ...

Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to InvestingPro data ...

Pinterest (NYSE:PINS – Free Report) had its target price upped by Cantor Fitzgerald from $36.00 to $48.00 in a research note ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

ORIC Pharmaceuticals Inc. (NASDAQ: ORIC) shares rose 12% following a recommendation from Cantor Fitzgerald to buy shares amid a possible leak of encouraging clinical trial data. Analyst Prakhar ...

Cantor Fitzgerald initiated coverage on shares of CACI International (NYSE:CACI – Free Report) in a research report released on Friday morning, Marketbeat Ratings reports. The firm issued an ...

A billionaire financier who lost more than 650 employees and his brother in the September 11 attacks, Howard Lutnick is ...

Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...

In a report released yesterday, Matthew Prisco from Cantor Fitzgerald maintained a Buy rating on Onto Innovation (ONTO – Research Report), with ...

It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...